Summary
Previous studies demonstrated that the structural changes to the heart that are associated with atrial fibrillation (AF) can be quantified using DE-MRI [Oakes RS et al. Circulation 2009]. This article presents data from the Delayed-Enhancement Magnetic Resonance Imaging (DE-MRI) Determinant of Successful Radiofrequency Catheter Ablation for Atrial Fibrillation trial [DECAAF; NCT01150214]. The DECAAF trial tested the hypothesis that DE-MRI can be used to determine the amount of left atrial fibrosis and/or remodeling, which predicts the patient's response to AF ablation.
- Cardiology Clinical Trials
- Arrhythmias
- Magnetic Resonance Imaging
- Cardiac Imaging Techniques
- Imaging Modalities
- Interventional Radiology
- Cardiology Clinical Trials
- Arrhythmias
- Magnetic Resonance Imaging
- Cardiology & Cardiovascular Medicine
- Cardiac Imaging Techniques
- Imaging Modalities
- Interventional Radiology
- © 2013 MD Conference Express®
Tools
DE-MRI Quantification of Atrial Fibrosis Predicts Ablation Outcome in Patients with Atrial Fibrillation
Permalink:
Table of contents
Cited By...
- No citing articles found.